Advertise on podcast: Outcomes Rocket

Virtual reality can remove the biggest barriers to evidence-based mental health treatment by making exposure therapy affordable, scalable, and accessible anywhere. In this episode, Adam Hutchinson, founder of oVRcome, discusses how lived experience with social anxiety and a background in technology led him to build a VR platform that expands access to exposure therapy worldwide. He explains why traditional exposure therapy is difficult, costly, and impractical for many conditions, and how VR “tricks the brain” to safely replicate real-world triggers without physical constraints. Adam explores the clinical value of immersive, filmed VR environments, the emerging role of generative AI in personalizing treatment, and the importance of maintaining realism for effective outcomes. He also shares insights from scaling a global startup from New Zealand, highlights use cases across self-help, clinicians, schools, payers, and health systems, and emphasizes the role of caregivers in successful treatment journeys. Tune in and discover how immersive technology is revolutionizing anxiety care, lowering costs, and increasing access to proven mental health treatments worldwide! Resources: Connect with and follow Adam Hutchinson on ⁠LinkedIn⁠. Follow oVRcome on ⁠LinkedIn⁠ and explore their ⁠website⁠. 

The most effective way to drive change in healthcare is to focus on what remains constant: serving patients. In this episode, sponsored by Amgen. Leandro Boer, Vice President of US Medical and General Medicines at Amgen, discusses how the company is reimagining care delivery to enhance access and outcomes, particularly for underserved populations. He explains how precision medicine, multi-omics, and advanced data use are driving innovation and preventing “data waste,” while Amgen invests heavily in R&D, including a $600 million Innovation and Discovery Science Center. Leandro highlights the role of technology in accelerating clinical trials through machine learning and anticipates three major shifts within the next five years: faster drug development, reduced administrative burden through the use of AI, and improved patient identification via care pathway automation. He also highlights Amgen’s goal to reduce cardiovascular events by 50% by 2030, the importance of diverse clinical representation through the RISE initiative, and the company’s commitment to employee well-being as the foundation for improved patient care. Tune in and learn how innovation, equity, and purpose-driven leadership are transforming the future of healthcare! Resources: Connect with and follow Leandro Boer on LinkedIn. Follow Amgen on LinkedIn and explore their website.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Aligned incentives change behavior faster than technology alone ever could. In this episode, Dr. Farzad Mostashari, co-founder and CEO of Aledade, discusses how value-based care finally makes prevention profitable by rewarding primary care for keeping patients healthy rather than treating avoidable disease. He reflects on his path from public health and federal EHR leadership to building a nationwide platform that partners with independent practices to take total-cost-of-care contracts. Dr. Mostashari covers why fee-for-service warped EHRs into billing tools, how accountable care models reversed that logic, and why culture, long-term thinking, and technology at scale matter. He shares results from thousands of practices achieving higher blood-pressure control by focusing on stroke prevention, explains the economics of Medicare Shared Savings and expanding private contracts, and explores how AI can deliver just-in-time insights across hundreds of EHRs without forcing workflow change.  Tune in and learn how aligning incentives, primary care, and AI can deliver better outcomes at lower cost! Resources: Connect with and follow Dr. Farzad Mostashari on LinkedIn. Follow Aledade on LinkedIn and discover their website. Follow Aledade on LinkedIn and visit their website. Check out Aledade's Public Benefit Report and Medicare Shared Savings Program announcement.

Peer support is becoming a core part of behavioral health, not just an add-on. In this episode, Shrenik Jain, founder and CEO of Marigold Health, and Robert McAlonan, Director of Behavioral Health at VNS Health, discuss how expanding the role of peer support can bridge the engagement gap in behavioral health. They share how their partnership is transforming access to care through a blend of technology and human connection, making services more accessible, private, and personalized. The conversation highlights how digital peer support offers a low-friction approach for individuals to seek help, thereby reducing hospitalizations and improving long-term recovery outcomes. Shrenik and Rob also explore the operational and systemic challenges of scaling peer support, from credentialing and integration to building value-based partnerships that reward outcomes. Tune in and learn how technology-driven peer support can reshape behavioral health access, engagement, and recovery outcomes! Resources: Connect with and follow Robert McAlonan on LinkedIn. Follow VNS Health on LinkedIn and visit their website.  Connect with and follow Shrenik Jain on LinkedIn. Follow Marigold Health on LinkedIn and visit their website.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Real AI in healthcare matters only if it delivers measurable value, not hype. In this episode, Justin Liu, CEO of Charta Health, discusses how AI is transforming medical record review by making it faster, cheaper, and scalable across all patient charts. He explains why chart review is central to nearly every healthcare workflow and how AI uncovers insights that manual sampling cannot. Justin shares how Charta helps high-volume outpatient providers increase revenue, improve clinical oversight, and consolidate fragmented processes into a single, customized platform. He also emphasizes the importance of provider-specific workflows and warns that AI is only as effective as the humans who train it. Tune in and learn how value-driven AI is reshaping healthcare operations at scale! Resources: Connect with and follow Justin Liu on LinkedIn. Follow Charta Health on LinkedIn and discover their website. Email Justin directly here.

High-quality behavioral healthcare scales only when outcomes, engagement, and coordination are designed into the system from day one. In this episode, Colleen Marshall, Chief Clinical Officer at Two Chairs, discusses how integrating therapy and psychiatry under one roof improves outcomes, reduces drop-off, and removes friction for patients. She explains measurement-based care (MBC), why real-time feedback in sessions drives better results, and how clinician training unlocks adoption. Colleen explores patient engagement, including why rapid access and strong matching matter and how coordinated care prevents conflicting treatment plans. She also breaks down value-based care in behavioral health, sharing how outcomes and retention can anchor shared-risk partnerships with payers. Finally, Colleen looks ahead to the future of behavioral health, including the responsible use of AI to support clinicians while maintaining ethical and effective care. Tune in and learn how outcomes, engagement, and coordination can redefine success in behavioral healthcare! Resources: Connect with and follow Colleen Marshall on LinkedIn. Follow Two Chairs on LinkedIn and visit their website.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Point-of-care engagement only works when technology serves real clinical workflows instead of forcing new ones. In this episode, Angelo Campano, CEO of Flora Health, discusses how his company bridges pharmaceutical manufacturers, health systems, and digital platforms to deliver relevant content to physicians at the exact moment of care. He explains how Flora helps brands show up inside EHR workflows without disrupting clinicians, why partnerships with health systems and technology vendors matter more than reinventing distribution, and how education closes the language gap between pharma and health IT. Angelo also shares the origin story behind Flora, his contrarian bet on market access over AI hype, and how automating prior authorization and patient assistance can dramatically improve access to therapy, especially for underserved populations. Drawing from his experience as an ultramarathon runner, he explains how “thinking in chapters” applies to building companies, measuring impact, and sustaining long-term innovation in healthcare. Tune in and learn how point-of-care strategy, market access, and disciplined execution can reshape patient access and outcomes! Resources Connect with and follow Angelo Campano on LinkedIn. Follow Flora Health on LinkedIn and visit their website!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com At-home blood testing is moving diagnostics out of clinics and into people’s lives, removing friction while expanding access to critical health insights. In this episode, Michael Dubrovsky, co-founder and CEO of SiPhox Health, discusses how his team is reimagining blood testing through painless at-home collection and advanced diagnostics focused on longevity and overlooked biomarkers. He explains why traditional blood testing in the U.S. is burdened by complexity, how SiPhox fills gaps left by primary care, and the growing consumer demand for deeper health data. Michael shares the origins of the company’s silicon photonics technology, the challenges of clinician trust and FDA clearance, and how home testing is already saving lives by identifying conditions like heart disease and hemochromatosis earlier. He also explores B2B use cases, funnel optimization, health equity, and why betting on fully home-based testing is a bold but necessary move for the future of healthcare. Tune in and learn how at-home diagnostics could fundamentally change how care is delivered and experienced! Resources: Connect with and follow Michael Dubrovsky on LinkedIn. Follow SiPhox Health on LinkedIn and visit their website! Listen to Michael’s podcast on Apple Podcasts or Spotify. Email Michael directly here.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Embedding trusted clinical evidence directly into everyday workflows is becoming critical to reducing burnout and improving clinical decision-making. In this episode, Christopher Sullivan, Vice President and General Manager of Pharmacy and Health Technology Solutions for Wolters Kluwer, discusses how the company is transforming from a traditional publishing company into a software-driven healthcare intelligence partner. He explains how products like UpToDate, Medi-Span, and Sentri7 function as an insight layer across retail pharmacies, hospitals, and the broader digital health ecosystem. A significant focus is UpToDate Connect, an API-based solution that embeds trusted clinical evidence directly into third-party platforms, keeping clinicians in workflow while reducing context switching. Christopher also shares early market feedback, highlighting efficiency gains, clinician confidence, and the importance of trusted content in an AI-driven world. Finally, he examines the future of agentic AI, non-clinical workflows, and the expanding role of partnerships in driving innovation.  Tune in and discover how evidence-based insights are shaping faster, more innovative, and more sustainable healthcare! Resources Connect with and follow Christopher Sullivan on LinkedIn.Follow Wolters Kluwer Health on LinkedIn and visit their website!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Accelerating drug development from ten years to one is possible when data, technology, and clinical trial design finally work together. In this episode, Bari Kowal, Senior Vice President of Development Operations & Portfolio Management for Regeneron, discusses how modernizing clinical trials, strengthening data infrastructure, and using AI responsibly can expand patient access and accelerate development. She emphasizes that education is a significant missing link in clinical research and that true progress depends on interoperability rather than flashy standalone tools. Bari highlights the need for clean, structured data and strong partnerships with health systems to integrate genetics, EMRs, and real-world information for more personalized and preventive medicine. She also explores the future of drug development, emphasising the importance of reducing cycle time, fostering regulatory collaboration, streamlining protocols, ensuring site readiness, and simplifying trial complexity while leveraging digital biomarkers effectively. Tune in and learn how thoughtful trial design, better data, and smarter collaboration can reinvent the path from discovery to patient impact! Resources Connect with and follow Bari Kowal on LinkedIn. Follow Regeneron on LinkedIn and visit their website!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Making healthcare access as simple as booking a table? Almost. In this episode, David Dyke, Chief Product Officer at Relatient, discusses how intelligent patient access is revolutionizing the healthcare experience. He explains why healthcare is far more complex than everyday consumer services and how Relatient uses organizational intelligence to streamline patient interactions across multiple channels. He dives into Dash, their platform that integrates with EMRs and practice systems, and shows how voice AI reduces repetitive tasks while guiding patients efficiently. Dyke emphasizes the importance of balancing automation with human touch to improve workflow and patient satisfaction. Tune in to hear how Relatient is simplifying healthcare access for patients and providers alike! Resources Connect with and follow David Dyke on LinkedIn. Follow Relatient on LinkedIn and explore their website!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Real-time transparency between payers and providers is becoming one of the most transformative levers in the healthcare industry. In this episode, Madhu Pawar, Chief Product Officer at Optum, discusses how her team is tackling the long-standing inefficiencies buried in today’s claims processes. She explains how Optum Real connects payers and providers through a real-time multi-party hub, uses AI to interpret contracts and encounter data, and equips providers with AI-first workflows that dramatically reduce denials, rework, and confusion for patients. Madhu also highlights early pilot results with Allina Health, demonstrating improvements in both patient experience and operational accuracy. She shares why 84% of first-time denied claims are avoidable, why eliminating that friction is at the core of Optum’s mission, and why value-based care will benefit enormously from real-time intelligence. Looking ahead, Madhu outlines a bold vision in which real-time payment flows, AI-enabled clinical insights, and improved data exchange reshape the entire system's operations. Tune in and learn how real-time transformation could redefine healthcare’s future! Resources Connect with and follow Madhu Pawar on LinkedIn. Follow Optum on LinkedIn and visit their website!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com AI is finally mature enough to move out of the way so nurses and clinicians can put humans back at the center of care.  In this episode, Mary Varghese Presti, Corporate Vice President of Microsoft Health and Life Sciences, discusses how global clinician shortages and rising acuity are colliding with an “AI frontier” that can reshape documentation, workflows, and patient outcomes. She shares her personal story as the daughter and former nurse who saw workforce gaps firsthand, then explains why Dragon Copilot for nurses was built to relieve documentation overload and capture the “invisible” work nurses do at the bedside. Mary breaks down the leap from copilots to agentic services, where digital colleagues take on predictable, nonclinical tasks and surface patterns clinicians would miss, as in Stanford’s AI-enabled tumor boards. Finally, she paints a future of hybrid human–digital teams and ambient, background technology that restores time, presence, and dignity to care.  Tune in and learn how AI can truly serve caregivers! Resources Connect with and follow Mary Varghese Presti on LinkedIn. Follow Microsoft on LinkedIn. Visit the Microsoft and Life Sciences website! Listen to Mary’s previous interview on our podcast here. Watch Mary’s keynote presentation at the HLTH conference here.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com This episode is brought to you by Censinet and Outcomes Rocket. Trust and regulation are the real bottlenecks preventing AI from safely transforming healthcare. In this episode, Brian Yam, Chief Operating Officer at Somnology, discusses the fast-evolving role of AI in healthcare, the risks of handling protected health information, and why building AI solutions internally can enhance security and regulatory control. He explains how medical-grade data, device-agnostic platforms, and strict cybersecurity standards are key to earning clinician trust and avoiding HIPAA breaches. Brian also explores AI regulation, human-in-the-loop systems, and why healthcare AI differs from consumer technology. He shares Sonology’s mission to improve sleep health, empower individuals with understandable medical data, and reflects on career risk-taking, leadership, and lessons from sports and law. Tune in and learn how trustworthy AI, medical-grade standards, and human oversight can responsibly shape the future of healthcare innovation! Resources: Connect with and follow Brian Yam on LinkedIn. Follow Somnology on LinkedIn and visit their website!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Clinical trials fail far more often due to flawed operations and unusable data than because of poor science. In this episode, Heather Grey, Senior Vice President and General Manager of Real World Data, Clinical Trials, and Registry at Omega Healthcare, explains why clinical research continues to stall despite scientific breakthroughs and growing excitement around AI. She details how messy data, underprepared sites, missed timelines, and gaps in education across patients, providers, and pharma create systemic delays that limit patient access and slow drug development. Heather shows how pairing clinical expertise with AI-driven data curation can produce FDA-grade data, keep trials on track, and enable more health systems to participate in research. She concludes by emphasizing that AI alone is insufficient, and that strong infrastructure, human quality assurance, and operational discipline are essential for expanding trial access and diversity. Tune in and learn how fixing execution, not chasing hype, is the real key to accelerating clinical trials! Resources: Connect with and follow Heather Grey on LinkedIn. Follow Omega Healthcare on LinkedIn and visit their website! Email Heather directly here.